NL-OMON35504尚未招募不适用
Safe, Strong & Onwards: Evaluation of a combined treatment program for offenders and victims of physical child abuse. - Effectiveness study SSO
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99(—)
入选标准
- •For the study children and their parents will be included only when:
- •- Child protective services (in Dutch: Bureau Jeugdzorg) is involved to guard the safety within the system and to underline the urgency of treatment.
- •- Parents give permission to acces the medical history of their children.
- •- Parents and children are financially and timewise able to participate in treatment.*
- •The inclusion criterium 'Parents and children are financially and timewise able to participate in treatment' pertains to the commitment clients have to make when the participate in treatment. In advance it should be considered if the client has sufficient financial resources to cover for travel expenses to both treatment sites. Furthermore, schools and employers shold have givene permission to be absent weekly if necessary and at variable hours. In reaction to your comment on treatment and compensation it should be noted that AMEA-compensation (Exceptional Medical Expenses Act) order when referral has taken place through Bureau Jeugdzorg (family and youth social work) to the KJTC (Trauma centre for Youths) and trough a general practitioner to De Waag (outpatient forensic/psychiatric treatment).
排除标准
- •The following exclusion criteria apply to treatment and therefore also to participating in the study:
- •- The guardian appointed by Child protective services (in Dutch: Bureau Jeugdzorg) cannot participate in (parts of) the treatment.
- •- Low intellectual functioning (IQ < 80) in parents or children.
- •- Insufficient ability to speak ur understand Dutch and no possibility to repeatedly collaborate with an interpreter.
- •- No motivation to change behavior patterns.
研究者
相似试验
招募中
不适用
Evaluation about safety and the effectiveness of the povidone iodine applicator once sterilization in the abdominal surgeryJPRN-UMIN000018231Toyohashi Municipal Hospital600
进行中(未招募)
1 期
Study to assess the long-term safety and tolerability of erenumab in migraine patientsMigraine prophylaxisMedDRA version: 20.0Level: PTClassification code 10027599Term: MigraineSystem Organ Class: 10029205 - Nervous system disordersEUCTR2019-002201-22-DEovartis Pharma GmbH640
尚未招募
不适用
Decreasing Defensive Responses: Investigating the Safe & Sound Protocol (SSP) to improve emotional regulation, communication, and social engagement with children with Autism.AutismACTRN12617001359325aTrobe University68
已完成
3 期
A Prospective Multicenter Trial to Assess the Safety and Effectiveness of the SYNERGYTM Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGYTM Stent System) for the Treatment of Atherosclerotic Lesion(s)Symptomatic coronary artery disease or documented silent ischemia10011082NL-OMON39360Boston Scientific International S.A.200
尚未招募
2 期
A Phase II, Multicentre, 2-part, Study of the Safety, Tolerability, and Efficacy of Intravitreal Fludrocortisone Acetate in Subjects with Geographic Atrophy Secondary to Age-related Macular Degeneration - Part BACTRN12624000997550EyeCo Pty Ltd126
